Recently, the National Institute for Health and Care Excellence (NICE) published a detailed strategy plan, outlining its vision during the next five years. Included in this report are new guidelines for technology evaluation, evidence standards, guidance adoption, and real-world data and research, which are applicable to all stakeholders, including the life science industry, regulators, healthcare providers, patients, and the public.

In this summary, PRECISIONheor Executive Vice President, Head of Medical Affairs Ross Maclean provides some key takeaways to life science innovators that help frame how NICE’s strategic framework may impact their business.

Click here to download the executive summary!